Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 17, 2020
The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumabJan Kolcava, Monika Hulova, Lucie Rihova, et al.BMC Neurology|August 24, 2022
Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case reportJan Kolcava, Aneta Rajdova, Eva Vlckova, et al.Multiple Sclerosis and Related Disorders|February 21, 2019
The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findingsJan Kolcava, Monika Hulova, Yvonne Benesova, et al.Multiple Sclerosis and Related Disorders|July 6, 2020
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case reportJan Kolcava, Jiri Litzman, Josef Bednarik, et al.Multiple Sclerosis and Related Disorders|January 23, 2024
Screening for dysphagia in patients with relapsing-remitting multiple sclerosisJan Kocica, Nadezda Lasotova, Jan Kolcava, et al.Journal of Rehabilitation Medicine|February 17, 2022
Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple SclerosisJan Kocica, Jan Kolcava, Michaela Sladeckova, et al.European Journal of Pain (London, England)|November 10, 2020
Sensory and pain modulation profiles of ongoing central neuropathic extremity pain in multiple sclerosisIva Srotova, Jan Kocica, Jan Vollert, et al.Pageof 1